Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 2
2006 4
2007 3
2008 3
2009 2
2010 2
2011 1
2012 1
2013 1
2015 1
2016 6
2017 2
2018 12
2019 5
2020 6
2021 11
2022 7
2023 6
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.
Gafita A, Calais J, Grogan TR, Hadaschik B, Wang H, Weber M, Sandhu S, Kratochwil C, Esfandiari R, Tauber R, Zeldin A, Rathke H, Armstrong WR, Robertson A, Thin P, D'Alessandria C, Rettig MB, Delpassand ES, Haberkorn U, Elashoff D, Herrmann K, Czernin J, Hofman MS, Fendler WP, Eiber M. Gafita A, et al. Among authors: d alessandria c. Lancet Oncol. 2021 Aug;22(8):1115-1125. doi: 10.1016/S1470-2045(21)00274-6. Epub 2021 Jul 8. Lancet Oncol. 2021. PMID: 34246328 Free article.
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
Feuerecker B, Tauber R, Knorr K, Heck M, Beheshti A, Seidl C, Bruchertseifer F, Pickhard A, Gafita A, Kratochwil C, Retz M, Gschwend JE, Weber WA, D'Alessandria C, Morgenstern A, Eiber M. Feuerecker B, et al. Among authors: d alessandria c. Eur Urol. 2021 Mar;79(3):343-350. doi: 10.1016/j.eururo.2020.11.013. Epub 2020 Dec 5. Eur Urol. 2021. PMID: 33293081
Can we produce an image of bacteria with radiopharmaceuticals?
Signore A, D'Alessandria C, Lazzeri E, Dierckx R. Signore A, et al. Among authors: d alessandria c. Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1051-5. doi: 10.1007/s00259-008-0762-9. Eur J Nucl Med Mol Imaging. 2008. PMID: 18398606 Free PMC article. No abstract available.
Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranostics.
Xue S, Gafita A, Zhao Y, Mercolli L, Cheng F, Rauscher I, D'Alessandria C, Seifert R, Afshar-Oromieh A, Rominger A, Eiber M, Shi K. Xue S, et al. Among authors: d alessandria c. Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3450-3460. doi: 10.1007/s00259-024-06737-3. Epub 2024 May 9. Eur J Nucl Med Mol Imaging. 2024. PMID: 38724653 Free PMC article.
New radiopharmaceuticals for imaging rheumatoid arthritis.
Chianelli M, D'Alessandria C, Conti F, Priori R, Valesini G, Annovazzi A, Signore A. Chianelli M, et al. Among authors: d alessandria c. Q J Nucl Med Mol Imaging. 2006 Sep;50(3):217-25. Q J Nucl Med Mol Imaging. 2006. PMID: 16868535 Free article. Review.
Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer.
Feuerecker B, Chantadisai M, Allmann A, Tauber R, Allmann J, Steinhelfer L, Rauscher I, Wurzer A, Wester HJ, Weber WA, d'Alessandria C, Eiber M. Feuerecker B, et al. Among authors: d alessandria c. J Nucl Med. 2022 Jun;63(6):833-839. doi: 10.2967/jnumed.121.262671. Epub 2021 Sep 16. J Nucl Med. 2022. PMID: 34531260 Free PMC article.
71 results